Low-Value Prostate-Specific Antigen Screening in Older Males

IMPORTANCE: The US Preventive Services Task Force guidelines advise against prostate-specific antigen (PSA) screening for prostate cancer in males older than 69 years due to the risk of false-positive results and overdiagnosis of indolent disease. However, this low-value PSA screening in males aged...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalavacherla, Sandhya, Riviere, Paul, Javier-DesLoges, Juan, Banegas, Matthew P., McKay, Rana R., Murphy, James D., Rose, Brent S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2023
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091155/
https://www.ncbi.nlm.nih.gov/pubmed/37040113
http://dx.doi.org/10.1001/jamanetworkopen.2023.7504

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091155/
https://www.ncbi.nlm.nih.gov/pubmed/37040113
http://dx.doi.org/10.1001/jamanetworkopen.2023.7504

Ejemplares similares